Proc Mixed for a non-replicate design [Software]

posted by kev – 2010-03-26 11:42 (5933 d 22:48 ago) – Posting: # 4976
Views: 4,713

Many thanks Gents. Both of you're replies seem to support my basic suspicion with the design theory here, that switching from a replicate design to a 4-way-crosssover to confirm treatment effects is a no-go.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
173 visitors (0 registered, 173 guests [including 18 identified bots]).
Forum time: 11:31 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5